May 2026 in “Reviews in Endocrine and Metabolic Disorders” The review addresses the impact of the global obesity epidemic on reproductive health, emphasizing the need for effective weight loss interventions during gestation to improve maternal and fetal health outcomes. It explores surgical and pharmacological strategies, with a focus on incretin-based therapies like GLP-1 receptor agonists and GIP dual agonists, which may enhance reproductive function and adapt to metabolic changes in pregnancy. These changes involve insulin signaling, lipid metabolism, and inflammatory regulation. The review also highlights the long-term risks of maternal obesity, such as increased likelihood of childhood obesity, underscoring the importance of managing gestational weight gain.
4 citations
,
January 2019 in “Therapeutic Advances in Endocrinology and Metabolism” Medications for PCOS don't seem to raise heart disease risk.
16 citations
,
September 2018 in “Journal of Ethnopharmacology” Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.
57 citations
,
May 2014 in “Molecular Phylogenetics and Evolution” The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.
December 2024 in “African Journal of Biomedical Research” Combining lifestyle changes and medication is most effective for managing PCOS symptoms.